BIND THERAPEUTICS (2BT.F)


Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.85-0.01 (-1.27%)
As of 2:09 AM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.85
Prev Close0.86
Bid0.85 x 538800
Ask0.95 x 403100
Day's Range0.85 - 0.85
52wk Range0.27 - 4.71
1y Target EstN/A
Market CapN/A
P/E Ratio (ttm)N/A
BetaN/A
Volume1,100
Avg Vol (3m)220
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Associated Press13 days ago

    Bind Therapeutics reports 2Q loss

    On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 43 cents. Losses, adjusted for non-recurring costs, came to 40 cents per share. The drug developer posted revenue ...

  • The Wall Street Journallast month

    [$$] Pfizer Cleared to Buy Nanotech Drug Firm Bind Therapeutics

    Pfizer won bankruptcy-court approval to buy the assets of Bind Therapeutics after an auction doubled Pfizer’s starting offer, for a final price of $40 million.

  • The Wall Street Journal2 months ago

    [$$] Pfizer Offers $20 Million for Bind Therapeutics Assets

    Pfizer Inc. has agreed to buy the assets of Bind Therapeutics Inc., a biotechnology company working on developing cancer treatments, out of bankruptcy for $20 million subject to higher bids at auction....